| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥25.3B | ¥22.0B | +15.3% |
| Operating Income | ¥0.8B | ¥-1.1B | +175.7% |
| Ordinary Income | ¥0.7B | ¥-1.2B | +158.0% |
| Net Income | ¥0.6B | ¥-1.6B | +139.7% |
| ROE | 1.6% | -4.2% | - |
FY2026 Q2 consolidated results show meaningful operational recovery with revenue reaching 25.3B yen (YoY +15.3%), marking a return to growth momentum. Operating income turned positive at 0.8B yen versus prior year loss of -1.1B yen (YoY +175.7%), ordinary income recorded 0.7B yen versus -1.2B yen (YoY +158.0%), and net income reached 0.6B yen compared to prior year loss of -1.6B yen (YoY +139.7%). The profit turnaround was driven by revenue expansion and gross margin maintenance at 31.1%, though offset by elevated SG&A expenses at 7.0B yen (27.8% of sales). Basic EPS improved significantly to 2.27 yen from -5.65 yen. However, operating cash flow deteriorated sharply to -1.7B yen (YoY -187.6%), creating a substantial disconnect between reported earnings and cash generation capability.
Revenue increased 3.4B yen to 25.3B yen (YoY +15.3%), reflecting recovery in core business demand and potential foreign exchange tailwinds. Cost of sales rose to 17.5B yen, yielding gross profit of 7.9B yen at 31.1% margin, maintaining year-over-year stability. The gross margin improvement from cost management was partially offset by SG&A expenses of 7.0B yen, representing 27.8% of revenue. While absolute SG&A declined from 7.6B yen prior year, the expense ratio improvement was modest given the 15% revenue growth, suggesting persistent fixed cost burden.
Operating income turned positive at 0.8B yen from -1.1B yen loss, with operating margin improving to 3.3% but remaining significantly below sustainable levels. Non-operating expenses totaled 0.2B yen, including interest expense of 0.1B yen and foreign exchange losses of 0.1B yen, resulting in net non-operating deficit of 0.1B yen. Ordinary income reached 0.7B yen, closely aligned with operating income, indicating limited impact from financial activities. Extraordinary items were minimal at net loss of 3.3M yen, including restructuring costs of 1.4M yen. The pre-tax income of 0.7B yen translated to net income of 0.6B yen after minimal tax expense of 3.6M yen, reflecting utilization of accumulated tax loss carryforwards. The pattern represents revenue up/profit up recovery, though profitability metrics remain at inflection point requiring sustained improvement.
[Profitability] ROE of 1.6% represents early-stage recovery from prior losses but remains substantially below industry norms, reflecting limited earnings power relative to equity base. Operating margin of 3.3% (versus -5.1% prior year) shows directional improvement but indicates continued margin compression challenges. Net profit margin of 2.4% improved from negative territory but trails sustainable levels. EBITDA of 1.8B yen yields EBITDA margin of 7.4%, with depreciation and amortization at 1.0B yen representing ongoing asset consumption. [Cash Quality] Cash and deposits totaled 10.1B yen, providing coverage of 1.27 times against combined short-term loans of 7.95B yen, indicating adequate liquidity buffer despite negative operating cash flow. However, cash conversion ratio of -0.91 times (operating CF/net income of -2.76) signals significant earnings quality concerns. [Investment Efficiency] Total asset turnover of 0.48 times reflects capital-intensive operations with moderate utilization. Return on assets of 1.2% and return on invested capital of approximately 2.2% both indicate suboptimal capital productivity. Accounts receivable increased to 9.2B yen (YoY +37.7%), creating DSO extension and working capital pressure. Inventories declined modestly to 5.1B yen but remain elevated relative to revenue run rate. [Financial Health] Equity ratio of 72.8% (versus 76.2% prior year) reflects strong solvency position with total equity of 38.5B yen supporting total assets of 52.8B yen. Current ratio of 256.7% and quick ratio of approximately 220.8% demonstrate robust short-term liquidity. However, short-term debt concentration reached 97.3% of total borrowings (7.95B yen short-term versus 0.22B yen long-term), creating refinancing risk. Debt-to-equity ratio of 0.21 times remains conservative, though debt-to-EBITDA of 4.44 times reflects profit generation constraints.
Operating cash flow of -1.7B yen represents a significant deterioration from -0.6B yen prior year, driven primarily by working capital expansion despite profit recovery. Operating subtotal before working capital changes was -1.5B yen, indicating negative operational earnings conversion. Trade receivables increased 3.1B yen year-over-year, absorbing substantial cash and extending collection cycles. Inventory consumption provided 0.4B yen inflow, while trade payables increased 0.8B yen, partially mitigating the receivables drain. The operating CF to net income ratio of -2.76 times reveals poor earnings quality, with accruals dominating reported profits. Investing cash flow of -0.4B yen consisted primarily of capital expenditures of 0.4B yen, representing 0.38 times depreciation expense and suggesting investment underrun relative to asset base maintenance requirements. Financing cash flow provided 2.7B yen, predominantly from net increase in short-term borrowings of 2.95B yen (from 5.0B to 7.95B yen), partially offset by long-term loan repayments of 0.2B yen and lease obligation payments of 5M yen. Free cash flow was negative 2.1B yen, indicating the company consumed cash from core operations and required external funding to sustain activities. Cash position declined by 0.1B yen to 10.1B yen after including subsidiary exclusion impact of 0.1B yen and exchange effects of 0.2B yen gain.
Operating income of 0.8B yen versus ordinary income of 0.7B yen shows net non-operating deficit of approximately 0.1B yen, representing minor impact at 0.4% of revenue. Non-operating income totaled 9M yen, comprising modest foreign exchange gains of 4M yen and miscellaneous items. Non-operating expenses of 25M yen included interest expense of 7M yen, reflecting borrowing costs on short-term debt, foreign exchange losses of 5M yen, and equity method losses of 13M yen from affiliate investments. The limited non-operating variance suggests core profitability is reasonably represented by operating results. However, operating cash flow of -1.7B yen versus net income of 0.6B yen creates a negative cash conversion ratio of -2.76, indicating substantial non-cash earnings components and working capital deterioration. The primary quality concern stems from accounts receivable expansion outpacing revenue growth (receivables +37.7% versus revenue +15.3%), suggesting either extended payment terms, collection delays, or potential revenue recognition timing issues. Comprehensive income of 1.0B yen exceeded net income by 0.4B yen due to foreign currency translation adjustments of 34M yen, reflecting overseas operations exposure but representing relatively minor impact on total equity.
Full-year guidance projects revenue of 50.0B yen (implying second half of 24.7B yen), operating income of 1.7B yen, ordinary income of 1.3B yen, and net income of 1.2B yen with basic EPS forecast of 4.21 yen. The company revised guidance during the current quarter. At Q2, achievement rates stand at 50.7% for revenue (25.3B/50.0B), 49.4% for operating income (0.8B/1.7B), 53.1% for ordinary income (0.7B/1.3B), indicating broadly on-track progress versus typical 50% midpoint benchmark for first half completion. However, the negative operating cash flow trajectory raises execution risk for second half targets, as sustained working capital expansion would pressure liquidity despite financing cushion. The revenue guidance implies YoY growth of +6.5% for the full year, decelerating from the first half pace of +15.3%, suggesting either conservative assumptions or anticipated headwinds in H2 market conditions.
The company paid no dividend for the current period, with both Q2 interim and forecast year-end dividends at zero. Prior year also recorded zero dividends, indicating continuation of dividend suspension policy. Given net income of 0.6B yen and zero dividend, payout ratio is 0%. The absence of dividend payments aligns with the company's financial position, where negative free cash flow of -2.1B yen and reliance on short-term borrowing increases of 2.95B yen provide no excess cash for shareholder distributions. Total return ratio including share buybacks is also 0%, as no repurchase activity was disclosed. Treasury stock holdings decreased to 0.5B yen from 1.2B yen, suggesting potential share issuance or retirement rather than new buyback activity. Until the company demonstrates sustained positive free cash flow and working capital normalization, dividend reinstatement appears unlikely.
Working capital deterioration risk: Accounts receivable surged 37.7% year-over-year to 9.2B yen while revenue grew 15.3%, creating DSO extension and potential collection issues. Combined with inventory of 5.1B yen and extended cash conversion cycle of 357 days reported, the company faces significant working capital strain that consumed 1.7B yen operating cash flow despite profit recovery. Failure to normalize receivables collection and inventory turnover would perpetuate external funding dependence and stress liquidity.
Short-term refinancing risk: Short-term borrowings increased to 7.95B yen, comprising 97.3% of total debt, while long-term debt declined to 0.22B yen. This concentration creates rollover risk at each maturity, particularly if operating cash flow remains negative and banks reassess credit appetite. Although current ratio of 256.7% provides coverage buffer, the mismatch between asset-liability duration and cash generation raises refinancing vulnerability.
Profitability sustainability risk: Operating margin of 3.3% and EBITDA margin of 7.4% remain below industry benchmarks, with operating income of only 0.8B yen insufficient to cover anticipated capital expenditure needs and debt service over time. The company's ROIC of 2.2% trails cost of capital, indicating value destruction absent margin expansion. Persistent cost structure rigidity or pricing pressure could reverse profit recovery and trigger return to losses.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin of 3.3% significantly trails the manufacturing industry median of 8.8% (IQR: 3.0%-11.0%), positioning the company in the lower quartile. Net profit margin of 2.4% also lags the industry median of 5.4% (IQR: 1.1%-8.2%). ROE of 1.6% substantially underperforms industry median of 4.4% (IQR: 1.4%-8.7%), reflecting weaker earnings generation relative to equity base. ROIC comparison similarly shows 2.2% versus industry median of 6.0% (IQR: 2.0%-14.0%).
Financial Health: Equity ratio of 72.8% exceeds the industry median of 48.6% (IQR: 26.7%-65.2%), indicating conservative capitalization and strong solvency position relative to manufacturing peers. Current ratio of 256.7% surpasses industry median of 2.74x (IQR: 2.27x-5.43x), confirming superior short-term liquidity coverage. However, this metric masks underlying working capital inefficiencies.
Efficiency: Asset turnover of 0.48 times outperforms industry median of 0.36 (IQR: 0.32-0.39), suggesting relatively better asset utilization despite capital intensity. Operating working capital turnover of 357 days substantially exceeds industry median of 169.52 days (IQR: 113.22-351.77 days), positioning the company in the bottom quartile and highlighting severe working capital management challenges. Cash conversion ratio of -0.91 compares unfavorably to industry median of 0.91 (IQR: -1.33-1.19), indicating weaker earnings quality versus peers.
Growth: Revenue growth of 15.3% exceeds industry median of 11.7% (IQR: -5.4%-28.3%), reflecting above-average top-line momentum. However, EPS growth of 140.2% versus industry median of 45.0% (IQR: -60.0%-96.0%) primarily reflects recovery from prior losses rather than sustainable expansion.
(※ Industry: Manufacturing sector, Comparison period: 2025-Q2 past 3 years, n=7 comparable companies, Source: Proprietary analysis)
Profit turnaround confirmed but cash generation disconnect persists: The company achieved decisive operating profit recovery to 0.8B yen from -1.1B yen loss, demonstrating successful revenue expansion and cost stabilization. However, operating cash flow deteriorated to -1.7B yen with cash conversion ratio of -0.91, creating a critical gap between reported earnings and cash realization. This pattern, driven by working capital expansion (particularly receivables +37.7%), signals earnings quality concerns requiring immediate management attention. The trajectory suggests profit improvement is accounting-based rather than cash-validated, warranting conservative assessment until working capital normalization occurs.
Liquidity adequacy maintained through short-term debt dependence: The company preserved adequate liquidity with 10.1B yen cash coverage of 1.27 times against short-term debt, supported by equity ratio of 72.8% and current ratio of 256.7%. However, 97.3% short-term debt concentration (7.95B yen) against declining long-term borrowings (0.22B yen) creates structural refinancing vulnerability. The 2.95B yen net increase in short-term loans during the period funded the negative operating and investing cash flows, establishing external funding dependence. Management's ability to extend debt maturity profiles and restore positive operating cash flow will determine medium-term financial flexibility and reduce rollover risk exposure.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.